> Products > CAS NO 1142-20-7

China CAS NO 1142-20-7 Factory

We support our consumers with ideal high-quality goods and substantial level support. Becoming the specialist manufacturer in this sector, we now have acquired abundant practical encounter in producing and managing for CAS NO 1142-20-7,1142-20-7,N-Carbobenzyloxy-L-alanine, Please truly feel absolutely free to call us at any time. We will reply you when we receive your inquiries. Please note that samples are available before we start our company.
CAS NO 1142-20-7, The best and original quality for spare parts is a most important factor for transportation. We may stick on supplying original and good quality parts even a little profit earned. God will bless us to do kindness business forever.

Hot Products

Docetaxel trihydrate
Product Name:Docetaxel trihydrate
Molecular Formula:C43H55NO15
Molecular Weight:825.91
CAS Registry Number:148408-66-6
(2R,4R,5S)-3-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid
Product Name:(2R,4R,5S)-3-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid
Molecular Formula:C22H25NO6
Molecular Weight:399.44
CAS Registry Number:859498-34-3
Doripenem Condensation Compound
Product Name:Doripenem Condensation Compound
Molecular Formula:C30H34N6O12S2
Molecular Weight:734.75
CAS Registry Number:491878-07-0
Pioglitazone hydrochloride
Product Name:Pioglitazone hydrochloride
Molecular Formula:C19H21ClN2O3S
Molecular Weight;392.9
CAS Registry Number;112529-15-4
Iguratimod
Product Name:Iguratimod
Molecular Formula:C17H14N2O6S
Molecular Weight:374.37
CAS Registry Number;123663-49-0
N-Boc-(2R,3R,4S)-dolaproine
Product Name:N-Boc-(2R,3R,4S)-dolaproine
Molecular Formula:C14H25NO5
Molecular Weight:287.35
CAS Registry Number:120205-50-7

Related Blog
Reviews

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)
Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.
Bosutinib CAS 380843-75-4
Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
Gilteritinib Fumarate
Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!
Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates
In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.
What Is Ursodeoxycholic Acid Used For?
Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

China CAS NO 1142-20-7 Factory

Related Products

Hot Products

Docetaxel trihydrate

(2R,4R,5S)-3-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid

Doripenem Condensation Compound

Pioglitazone hydrochloride

Iguratimod

N-Boc-(2R,3R,4S)-dolaproine

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

Bosutinib CAS 380843-75-4

Gilteritinib Fumarate

Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

What Is Ursodeoxycholic Acid Used For?

Michaelia 2023-06-27 13:31:22

Kay 2023-10-16 19:46:58

Geraldine 2022-12-21 16:58:23

Gwendolyn 2023-01-26 18:36:52

Sara 2022-08-26 16:05:05

Fanny 2024-02-23 17:59:35

Send Inquiry